We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $12.2B
1-Year Est. Return 12.45%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+12.45%
3 Year Est. Return
+44.66%
5 Year Est. Return
+68.67%
10 Year Est. Return
+295.88%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSTR icon
101
Landstar System
LSTR
$7.18B
$21.6M 0.32%
207,370
+27,714
+15% +$2.78M
SYY icon
102
Sysco
SYY
$39.1B
$21.5M 0.31%
353,538
-24,790
-7% -$1.4M
VAR
103
DELISTED
Varian Medical Systems, Inc.
VAR
$21.5M 0.31%
193,091
-1,915
-1% -$206K
IDCC icon
104
InterDigital
IDCC
$6.73B
$20.9M 0.31%
274,963
-7,961
-3% -$595K
CUBE icon
105
CubeSmart
CUBE
$9.48B
$20.6M 0.3%
713,311
+145,853
+26% +$4.07M
MZTI
106
The Marzetti Company
MZTI
$2.94B
$20.5M 0.3%
158,943
+24,594
+18% +$3.1M
USPH icon
107
US Physical Therapy
USPH
$1.12B
$20.3M 0.3%
280,557
+1,952
+0.7% +$133K
INVX
108
Innovex International
INVX
$1.8B
$20M 0.29%
419,248
+120,858
+41% +$5.4M
HRC
109
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$19.8M 0.29%
235,490
-4,274
-2% -$346K
MRSH
110
Marsh
MRSH
$87.8B
$19.5M 0.29%
239,555
+32,770
+16% +$2.72M
CVX icon
111
Chevron
CVX
$373B
$19.5M 0.29%
155,404
+16,077
+12% +$1.91M
BKNG icon
112
Booking.com
BKNG
$141B
$19.3M 0.28%
277,075
+5,825
+2% +$422K
MD icon
113
Pediatrix Medical
MD
$2.15B
$19.2M 0.28%
359,011
+285,955
+391% +$13.5M
TECH icon
114
Bio-Techne
TECH
$11.2B
$18.9M 0.28%
582,120
-11,452
-2% -$364K
MCD icon
115
McDonald's
MCD
$190B
$18.7M 0.27%
108,520
-2,192
-2% -$368K
TCBI icon
116
Texas Capital Bancshares
TCBI
$4.59B
$18.6M 0.27%
209,107
-2,521
-1% -$218K
LHO
117
DELISTED
LaSalle Hotel Properties
LHO
$17.8M 0.26%
633,952
-16,177
-2% -$464K
TEL icon
118
TE Connectivity
TEL
$59.3B
$17.6M 0.26%
185,230
+125,560
+210% +$11.6M
POWI icon
119
Power Integrations
POWI
$3.93B
$17.4M 0.26%
473,680
+17,062
+4% +$651K
MLKN icon
120
MillerKnoll
MLKN
$1.49B
$17.3M 0.25%
433,071
-10,116
-2% -$355K
EGOV
121
DELISTED
NIC Inc
EGOV
$17.3M 0.25%
1,044,009
-60,800
-6% -$1.03M
CVBF icon
122
CVB Financial
CVBF
$4.03B
$17.1M 0.25%
727,079
-20,322
-3% -$483K
CMA
123
DELISTED
Comerica
CMA
$17M 0.25%
196,099
-220
-0.1% -$17.7K
SKT icon
124
Tanger
SKT
$4.8B
$17M 0.25%
641,453
-48,787
-7% -$1.21M
POLY
125
DELISTED
Plantronics, Inc.
POLY
$16.9M 0.25%
335,945
-107,398
-24% -$5.28M
3 4
5
6 7

Similar funds

GLA
Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return
PIF
Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $12B AUM 27.64% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $12.4B AUM 25.9% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $12.4B AUM 17.21% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $11.9B AUM 10.84% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $12.4B AUM 29.42% 1-Year Est. Return
LC
Loews Corp New York $11.9B AUM 8.99% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.